Why does this matter? Epigenetic clocks measure biological age by looking at chemical changes (DNA methylation) that accumulate over time and correlate with aging and disease risk. Previous work suggests obesity accelerates aging, but most epigenetic clock studies have been conducted in high-income countries. This study addresses a gap by examining whether these clocks work similarly in a young, lower-middle income population from the Philippines—a health disparity question that's often overlooked in longevity research.
What did they do? The researchers analyzed 1,745 young Filipino adults (average age 21.7 years, 45% female) from a long-running nutrition survey. They measured body composition three ways (BMI, waist circumference, and waist-to-height ratio) and biological age using six different epigenetic clocks—PCHorvath 2, PCHannum, PCPhenoAge, PCGrimAge, PCDNAmTL, and DunedinPACE. Crucially, they used factor analysis (a statistical technique) to combine all six clocks into two composite measures, reasoning that combining multiple imperfect clocks might yield a more reliable estimate of true biological aging.
What did they find? All three adiposity measures (BMI, waist circumference, waist-to-height ratio) showed consistent positive associations with the composite biological age scores. For example, a 5 kg/m² increase in BMI corresponded to a 0.097–0.099 standard deviation increase in composite biological age. Waist-to-height ratio showed the strongest associations. Notably, several individual clocks (especially PhenoAge and DunedinPACE) also independently predicted higher biological age with increased adiposity, suggesting this isn't an artifact of one clock.
What are the limitations? This is a preprint—not yet peer-reviewed, so methods and conclusions haven't been vetted by independent experts. The sample is young and from one geographic region, limiting generalizability. Cross-sectional design means we can't determine whether adiposity causes accelerated aging or if both arise from a common cause. The composite biological age measures are novel and haven't been validated against health outcomes. Small effect sizes (0.09–0.16 SD) raise questions about clinical meaningfulness. Finally, zero citations suggest this is very recent work.
What does this mean for longevity research? The study demonstrates a methodological innovation—combining multiple epigenetic clocks—that could improve biological age assessment reliability. It also extends epigenetic clock research to an understudied population, strengthening the evidence that adiposity and biological age acceleration are linked across diverse ancestries. However, the findings are preliminary: we need peer review, replication in other populations, and prospective studies showing whether these biological age accelerations actually predict real health outcomes (disease, mortality) in this cohort.
0 Comments
Log in to join the discussion.